Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design by Katz, Matthew H. G., Marsh, Robert, Herman, Joseph M., Shi, Qian, Collison, Eric, Venook, Alan P., Kindler, Hedy L., Alberts, Steven R., Philip, Philip, Lowy, Andrew M., Pisters, Peter W. T., Posner, Mitchell C., Berlin, Jordan D., Ahmad, Syed A.

Get full text

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-la... by Marabelle, Aurélien, Fakih, Marwan, Lopez, Juanita, Shah, Manisha, Shapira-Frommer, Ronnie, Nakagawa, Kazuhiko, Chung, Hyun Cheol, Kindler, Hedy L, Lopez-Martin, Jose A, Miller, Wilson H, Italiano, Antoine, Kao, Steven, Piha-Paul, Sarina A, Delord, Jean-Pierre, McWilliams, Robert R, Fabrizio, David A, Aurora-Garg, Deepti, Xu, Lei, Jin, Fan, Norwood, Kevin, Bang, Yung-Jue

Get full text

MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma by Kanteti, Rajani, Dhanasingh, Immanuel, Kawada, Ichiro, Lennon, Frances E, Arif, Qudsia, Bueno, Raphael, Hasina, Rifat, Husain, Aliya N, Vigneswaran, Wickii, Seiwert, Tanguy, Kindler, Hedy L, Salgia, Ravi

Get full text

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase... by Maio, Michele, Scherpereel, Arnaud, Calabrò, Luana, Aerts, Joachim, Perez, Susana Cedres, Bearz, Alessandra, Nackaerts, Kristiaan, Fennell, Dean A, Kowalski, Dariusz, Tsao, Anne S, Taylor, Paul, Grosso, Federica, Antonia, Scott J, Nowak, Anna K, Taboada, Maria, Puglisi, Martina, Stockman, Paul K, Kindler, Hedy L

Get full text

Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy by Hassan, Raffit, Morrow, Betsy, Thomas, Anish, Walsh, Tom, Lee, Ming K., Gulsuner, Suleyman, Gadiraju, Meghana, Panou, Vasiliki, Gao, Shaojian, Mian, Idrees, Khan, Javed, Raffeld, Mark, Patel, Snehal, Xi, Liqiang, Wei, Jun S., Hesdorffer, Mary, Zhang, Jingli, Calzone, Kathleen, Desai, Arpita, Padiernos, Emerson, Alewine, Christine, Schrump, David S., Steinberg, Seth M., Kindler, Hedy L., King, Mary-Claire, Churpek, Jane E.

Get full text

EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach by Nicholson, Andrew G., Sauter, Jennifer L., Nowak, Anna K., Kindler, Hedy L., Gill, Ritu R., Remy-Jardin, Martine, Armato, Samuel G., Fernandez-Cuesta, Lynnette, Bueno, Raphael, Alcala, Nicolas, Foll, Matthieu, Pass, Harvey, Attanoos, Richard, Baas, Paul, Beasley, Mary Beth, Brcic, Luka, Butnor, Kelly J., Chirieac, Lucian R., Churg, Andrew, Courtiol, Pierre, Dacic, Sanja, De Perrot, Marc, Frauenfelder, Thomas, Gibbs, Allen, Hirsch, Fred R., Hiroshima, Kenzo, Husain, Aliya, Klebe, Sonja, Lantuejoul, Sylvie, Moreira, Andre, Opitz, Isabelle, Perol, Maurice, Roden, Anja, Roggli, Victor, Scherpereel, Arnaud, Tirode, Frank, Tazelaar, Henry, Travis, William D., Tsao, Ming-Sound, van Schil, Paul, Vignaud, Jean Michel, Weynand, Birgit, Lang-Lazdunski, Loic, Cree, Ian, Rusch, Valerie W., Girard, Nicolas, Galateau-Salle, Francoise

Get full text

Understanding the new therapeutic options for mesothelioma by Kindler, Hedy Lee

Get full text

The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma by Nowak, Anna K., Chansky, Kari, Pass, Harvey I., Kindler, Hedy L., Shemanski, Lynn, Billé, Andrea, Rintoul, Robert C., Batirel, Hasan F., Thomas, Charles F., Friedberg, Joseph, de Perrot, Marc, Rusch, Valerie W., Goldstraw, Peter, Rami-Porta, Ramón, Asamura, Hisao, Beer, David, Beyruti, Ricardo, Chansky, Kari, Crowley, John, Eberhardt, Wilfried Ernst Erich, Edwards, John, Galateau-Sallé, Françoise, Giroux, Dorothy, Gleeson, Fergus, Groome, Patti, Huang, James, Kennedy, Catherine, Kim, Jhingook, Kim, Young Tae, Kingsbury, Laura, Kondo, Haruhiko, Krasnik, Mark, Kubota, Kaoru, Lerut, Antoon, Lyons, Gustavo, Marino, Mirella, van Meerbeeck, Jan, Nakano, Takashi, Nicholson, Andrew G., Nowak, Anna, Peake, Michael, Rice, Thomas, Rosenzweig, Kenneth, Ruffini, Enrico, Rusch, Valerie, Saijo, Nagahiro, Van Schil, Paul, Sculier, Jean-Paul, Shemanski, Lynn, Stratton, Kelly, Suzuki, Kenji, Tachimori, Yuji, Thomas, Charles F., Travis, William, Tsao, Ming S., Turrisi, Andrew, Watanabe, Hirokazu, Wu, Yi-Long, Baas, Paul, Erasmus, Jeremy, Hasegawa, Seiki, Inai, Kouki, Kindler, Hedy, Nackaerts, Kristiaan, Pass, Harvey, Rice, David, Falkson, Conrad, Filosso, Pier Luigi, Kondo, Kazuya, Lucchi, Marco, Okumura, Meinoshin, Blackstone, Eugene, Batirel, H., Bille, A., Pastorino, U., Call, S., Cedres, S., Friedberg, J., Hasagawa, S., Kindler, H., McCaughan, B., Nakano, T., Nowak, A., Ozturk, C. Atinkaya, Pass, H., de Perrot, M., Rea, F., Rice, D., Rintoul, R., Ruffini, E., Rusch, V., Spaggiari, L, Galetta, D, Thomas, C., van Meerbeeck, J., Nafteux, P., Vansteenkiste, J., Weder, W., Optiz, I., Yoshimura, M.

Get full text

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-control... by Krug, Lee M, Dr, Kindler, Hedy L, Prof, Calvert, Hilary, MD, Manegold, Christian, Prof, Tsao, Anne S, MD, Fennell, Dean, Prof, Öhman, Ronny, MD, Plummer, Ruth, Prof, Eberhardt, Wilfried E E, MD, Fukuoka, Kazuya, MD, Gaafar, Rabab M, Prof, Lafitte, Jean-Jacques, Prof, Hillerdal, Gunnar, MD, Chu, Quincy, MD, Buikhuisen, Wieneke A, MD, Lubiniecki, Gregory M, MD, Sun, Xing, PhD, Smith, Margaret, BA, Baas, Paul, Prof

Get full text

Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma by Hassan, Raffit, Kindler, Hedy L, Jahan, Thierry, Bazhenova, Lyudmila, Reck, Martin, Thomas, Anish, Pastan, Ira, Parno, Jeff, O'Shannessy, Daniel J, Fatato, Penny, Maltzman, Julia D, Wallin, Bruce A

Get full text

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild‐type BRCA pancreatic ductal adenocarcinoma by O'Reilly, Eileen M., Lee, Jonathan W., Lowery, Maeve A., Capanu, Marinela, Stadler, Zsofia K., Moore, Malcolm J., Dhani, Neesha, Kindler, Hedy L., Estrella, Hayley, Maynard, Hannah, Golan, Talia, Segal, Amiel, Salo‐Mullen, Erin E., Yu, Kenneth H., Epstein, Andrew S., Segal, Michal, Brenner, Robin, Do, Richard K., Chen, Alice P., Tang, Laura H., Kelsen, David P.

Get full text

Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma by Kanteti, Rajani, Mirzapoiazova, Tamara, Riehm, Jacob J., Dhanasingh, Immanuel, Mambetsariev, Bolot, Wang, Jiale, Kulkarni, Prakash, Kaushik, Garima, Seshacharyulu, Parthasarathy, Ponnusamy, Moorthy P., Kindler, Hedy L., Nasser, Mohd W., Batra, Surinder K., Salgia, Ravi

Get full text

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study by Kindler, Hedy L, Dr, Ioka, Tatsuya, MD, Richel, Dirk J, MD, Bennouna, Jaafar, MD, Létourneau, Richard, MD, Okusaka, Takuji, MD, Funakoshi, Akihiro, MD, Furuse, Junji, MD, Park, Young Suk, MD, Ohkawa, Shinichi, MD, Springett, Gregory M, MD, Wasan, Harpreet S, MB, Trask, Peter C, PhD, Bycott, Paul, PhD, Ricart, Alejandro D, MD, Kim, Sinil, MD, Van Cutsem, Eric, MD

Get full text

ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma by Bansal, Varun V., Mitchell, Owen, Drazer, Michael W., Kindler, Hedy L., Turaga, Kiran K.

Get full text

Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation by Berger, Yaniv, Gadiraju, Meghana, Dhiman, Ankit, Gilliam, Katie, Opalecky, Buerkley, Chen, Heather, Helgeson, Maria, Eng, Oliver S., Husain, Aliya N., Drazer, Michael W., Kindler, Hedy L., Churpek, Jane E., Turaga, Kiran K.

Get full text

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for... by Tsao, Anne S., Lindwasser, O. Wolf, Adjei, Alex A., Adusumilli, Prasad S., Beyers, Matthew L., Blumenthal, Gideon M., Bueno, Raphael, Burt, Bryan M., Carbone, Michele, Dahlberg, Suzanne E., de Perrot, Marc, Fennell, Dean A., Friedberg, Joseph, Gill, Ritu R., Gomez, Daniel R., Harpole, David H., Hassan, Raffit, Hesdorffer, Mary, Hirsch, Fred R., Hmeljak, Julija, Kindler, Hedy L., Korn, Edward L., Liu, Geoffrey, Mansfield, Aaron S., Nowak, Anna K., Pass, Harvey I., Peikert, Tobias, Rimner, Andreas, Robinson, Bruce W.S., Rosenzweig, Kenneth E., Rusch, Valerie W., Salgia, Ravi, Sepesi, Boris, Simone, Charles B., Sridhara, Rajeshwari, Szlosarek, Peter, Taioli, Emanuela, Tsao, Ming-Sound, Yang, Haining, Zauderer, Marjorie G., Malik, Shakun M.

Get full text

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma by Lowery, Maeve A., Kelsen, David P., Capanu, Marinela, Smith, Sloane C., Lee, Jonathan W., Stadler, Zsofia K., Moore, Malcolm J., Kindler, Hedy L., Golan, Talia, Segal, Amiel, Maynard, Hannah, Hollywood, Ellen, Moynahan, MaryEllen, Salo-Mullen, Erin E., Do, Richard Kinh Gian, Chen, Alice P., Yu, Kenneth H., Tang, Laura H., O'Reilly, Eileen M.

Get full text

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma by Pectasides, Eirini, Stachler, Matthew D, Derks, Sarah, Liu, Yang, Maron, Steven, Islam, Mirazul, Alpert, Lindsay, Kwak, Heewon, Kindler, Hedy, Polite, Blase, Sharma, Manish R, Allen, Kenisha, O'Day, Emily, Lomnicki, Samantha, Maranto, Melissa, Kanteti, Rajani, Fitzpatrick, Carrie, Weber, Christopher, Setia, Namrata, Xiao, Shu-Yuan, Hart, John, Nagy, Rebecca J, Kim, Kyoung-Mee, Choi, Min-Gew, Min, Byung-Hoon, Nason, Katie S, O'Keefe, Lea, Watanabe, Masayuki, Baba, Hideo, Lanman, Rick, Agoston, Agoston T, Oh, David J, Dunford, Andrew, Thorner, Aaron R, Ducar, Matthew D, Wollison, Bruce M, Coleman, Haley A, Ji, Yuan, Posner, Mitchell C, Roggin, Kevin, Turaga, Kiran, Chang, Paul, Hogarth, Kyle, Siddiqui, Uzma, Gelrud, Andres, Ha, Gavin, Freeman, Samuel S, Rhoades, Justin, Reed, Sarah, Gydush, Greg, Rotem, Denisse, Davison, Jon, Imamura, Yu, Adalsteinsson, Viktor, Lee, Jeeyun, Bass, Adam J, Catenacci, Daniel V

Get full text

Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 c... by Chapel, David B., Schulte, Jefree J., Absenger, Gudrun, Attanoos, Richard, Brcic, Luka, Butnor, Kelly J., Chirieac, Lucian, Churg, Andrew, Galateau-Sallé, Françoise, Hiroshima, Kenzo, Hung, Yin P., Kindler, Hedy, Krausz, Thomas, Marchevsky, Alberto, Mino-Kenudson, Mari, Mueller, Jeffrey, Nabeshima, Kazuki, Turaga, Kirin, Walts, Ann E., Husain, Aliya N.

Get full text

Patient‐centered outcomes in the POLO study of active maintenance olaparib for germline BRCA‐mutated metastatic pancreatic cancer by Kindler, Hedy L., Yoo, Hyun Kyoo, Hettle, Robert, Cui, Karen Y., Joo, Seongjung, Locker, Gershon Y., Golan, Talia

Get full text